Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 18007 | 43.31 |
09:34 ET | 400 | 43.035 |
09:36 ET | 600 | 43.015 |
09:38 ET | 1219 | 42.99 |
09:39 ET | 550 | 42.74 |
09:43 ET | 900 | 42.7175 |
09:45 ET | 1795 | 42.6 |
09:48 ET | 1245 | 42.41 |
09:50 ET | 2100 | 42.1301 |
09:52 ET | 5073 | 42.145 |
09:54 ET | 5200 | 42.2 |
09:56 ET | 3864 | 42.165 |
09:57 ET | 21436 | 42.15 |
09:59 ET | 3951 | 42.26 |
10:01 ET | 2000 | 42.235 |
10:03 ET | 854 | 42.19 |
10:06 ET | 4968 | 42.185 |
10:08 ET | 7349 | 42.115 |
10:10 ET | 740 | 42.125 |
10:12 ET | 1207 | 42.13 |
10:14 ET | 500 | 42.16 |
10:15 ET | 500 | 42.08 |
10:17 ET | 1631 | 42.06 |
10:19 ET | 2201 | 41.99 |
10:21 ET | 4231 | 41.945 |
10:24 ET | 1761 | 41.975 |
10:26 ET | 1990 | 41.975 |
10:28 ET | 349 | 41.97 |
10:30 ET | 513 | 42.01 |
10:32 ET | 3353 | 41.935 |
10:33 ET | 3208 | 41.99 |
10:37 ET | 1000 | 42.025 |
10:39 ET | 2123 | 42.06 |
10:42 ET | 700 | 42.065 |
10:44 ET | 1314 | 42.02 |
10:46 ET | 100 | 42.01 |
10:48 ET | 1100 | 42.035 |
10:50 ET | 1650 | 42 |
10:51 ET | 200 | 42.01 |
10:53 ET | 7299 | 41.9 |
10:55 ET | 400 | 41.76 |
10:57 ET | 1134 | 41.71 |
11:00 ET | 1309 | 41.65 |
11:02 ET | 1360 | 41.6 |
11:04 ET | 1764 | 41.56 |
11:06 ET | 7112 | 41.47 |
11:08 ET | 826 | 41.5 |
11:09 ET | 1200 | 41.5 |
11:11 ET | 400 | 41.46 |
11:13 ET | 500 | 41.53 |
11:15 ET | 2837 | 41.3534 |
11:18 ET | 7747 | 41.41 |
11:20 ET | 2499 | 41.385 |
11:22 ET | 1503 | 41.36 |
11:24 ET | 3143 | 41.3 |
11:26 ET | 278 | 41.31 |
11:27 ET | 1662 | 41.23 |
11:29 ET | 1720 | 41.255 |
11:31 ET | 8884 | 41.365 |
11:33 ET | 3558 | 41.385 |
11:36 ET | 500 | 41.385 |
11:38 ET | 2967 | 41.305 |
11:40 ET | 1540 | 41.22 |
11:42 ET | 2200 | 41.295 |
11:44 ET | 20993 | 41.435 |
11:45 ET | 100 | 41.44 |
11:47 ET | 1355 | 41.42 |
11:49 ET | 1362 | 41.455 |
11:51 ET | 2623 | 41.36 |
11:54 ET | 720 | 41.35 |
11:56 ET | 7989 | 41.15 |
11:58 ET | 7775 | 41.14 |
12:00 ET | 18203 | 41.26 |
12:02 ET | 3538 | 41.31 |
12:03 ET | 4700 | 41.365 |
12:05 ET | 900 | 41.365 |
12:07 ET | 2650 | 41.345 |
12:09 ET | 14128 | 41.42 |
12:12 ET | 2504 | 41.45 |
12:14 ET | 300 | 41.48 |
12:16 ET | 500 | 41.46 |
12:18 ET | 1902 | 41.425 |
12:20 ET | 3721 | 41.56 |
12:23 ET | 1200 | 41.56 |
12:27 ET | 1000 | 41.555 |
12:30 ET | 800 | 41.53 |
12:32 ET | 4256 | 41.535 |
12:34 ET | 357 | 41.54 |
12:36 ET | 300 | 41.53 |
12:38 ET | 500 | 41.48 |
12:39 ET | 2970 | 41.46 |
12:41 ET | 3925 | 41.745 |
12:43 ET | 900 | 41.79 |
12:45 ET | 10603 | 41.85 |
12:48 ET | 900 | 41.92 |
12:50 ET | 2403 | 41.93 |
12:52 ET | 100 | 41.96 |
12:54 ET | 1750 | 42.065 |
12:56 ET | 4267 | 42.01 |
12:57 ET | 200 | 42.04 |
12:59 ET | 1500 | 42.09 |
01:01 ET | 100 | 42.055 |
01:03 ET | 400 | 42.055 |
01:06 ET | 100 | 42.05 |
01:08 ET | 100 | 42.06 |
01:10 ET | 3500 | 42 |
01:12 ET | 2300 | 42.135 |
01:14 ET | 330 | 42.09 |
01:15 ET | 900 | 42.18 |
01:19 ET | 115 | 42.19 |
01:21 ET | 1627 | 42.22 |
01:24 ET | 885 | 42.185 |
01:26 ET | 1037 | 42.15 |
01:28 ET | 700 | 42.2 |
01:30 ET | 300 | 42.24 |
01:32 ET | 1500 | 42.24 |
01:33 ET | 1200 | 42.32 |
01:35 ET | 500 | 42.36 |
01:37 ET | 100 | 42.395 |
01:39 ET | 200 | 42.425 |
01:42 ET | 2387 | 42.34 |
01:44 ET | 200 | 42.355 |
01:46 ET | 1653 | 42.385 |
01:48 ET | 404 | 42.34 |
01:50 ET | 6697 | 42.255 |
01:51 ET | 230 | 42.26 |
01:53 ET | 3395 | 42.2 |
01:55 ET | 700 | 42.215 |
01:57 ET | 230 | 42.215 |
02:00 ET | 400 | 42.225 |
02:02 ET | 300 | 42.16 |
02:04 ET | 1713 | 42.18 |
02:06 ET | 2131 | 42.12 |
02:08 ET | 3503 | 42.13 |
02:09 ET | 600 | 42.165 |
02:11 ET | 300 | 42.17 |
02:13 ET | 2261 | 42.14 |
02:15 ET | 1123 | 42.145 |
02:18 ET | 500 | 42.1 |
02:20 ET | 317 | 42.1 |
02:22 ET | 100 | 42.065 |
02:24 ET | 6470 | 42.035 |
02:26 ET | 3100 | 42.065 |
02:27 ET | 1872 | 41.97 |
02:29 ET | 3796 | 42 |
02:31 ET | 698 | 41.955 |
02:33 ET | 768 | 41.85 |
02:36 ET | 200 | 41.86 |
02:38 ET | 450 | 41.92 |
02:40 ET | 855 | 41.84 |
02:42 ET | 10440 | 41.895 |
02:44 ET | 200 | 41.88 |
02:45 ET | 200 | 41.885 |
02:47 ET | 1681 | 41.9 |
02:49 ET | 2300 | 41.91 |
02:51 ET | 200 | 41.92 |
02:54 ET | 491 | 41.92 |
02:56 ET | 693 | 41.9 |
02:58 ET | 1589 | 41.905 |
03:00 ET | 1330 | 41.93 |
03:02 ET | 2210 | 41.97 |
03:03 ET | 1094 | 42.035 |
03:05 ET | 628 | 42.04 |
03:07 ET | 3076 | 41.985 |
03:09 ET | 800 | 41.97 |
03:12 ET | 500 | 41.945 |
03:14 ET | 39014 | 41.885 |
03:16 ET | 1634 | 41.8 |
03:18 ET | 1500 | 41.895 |
03:20 ET | 4360 | 42.01 |
03:21 ET | 6054 | 41.87 |
03:23 ET | 1016 | 41.91 |
03:25 ET | 1500 | 41.89 |
03:30 ET | 330 | 41.87 |
03:32 ET | 4198 | 41.885 |
03:34 ET | 1323 | 41.89 |
03:36 ET | 3577 | 41.82 |
03:38 ET | 1034 | 41.83 |
03:39 ET | 4766 | 41.785 |
03:41 ET | 1332 | 41.8 |
03:43 ET | 2374 | 41.8 |
03:45 ET | 1598 | 41.79 |
03:48 ET | 3714 | 41.71 |
03:50 ET | 920 | 41.74 |
03:52 ET | 7755 | 41.715 |
03:54 ET | 14469 | 41.565 |
03:56 ET | 17378 | 41.62 |
03:57 ET | 13462 | 41.62 |
03:59 ET | 192773 | 41.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 7.7B | -15.9x | --- |
Ascendis Pharma A/S | 7.4B | -13.1x | --- |
Blueprint Medicines Corp | 6.6B | -21.5x | --- |
Intra-Cellular Therapies Inc | 7.2B | -59.8x | --- |
Cerevel Therapeutics Holdings Inc | 7.6B | -15.2x | --- |
Vaxcyte Inc | 7.9B | -17.0x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.7B |
---|---|
Revenue (TTM) | $342.8M |
Shares Outstanding | 182.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.10 |
EPS | $-2.60 |
Book Value | $6.88 |
P/E Ratio | -15.9x |
Price/Sales (TTM) | 22.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -157.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.